AllianceBernstein’s Filana Therapeutics FLNA Stock Holding History

AllianceBernstein’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-37,000	Closed	-$55.5K	–	3320
2025 Q1	$55.5K	Sell	37,000 -1,200	-3%	-$3.03K	﹤0.01%	3122
2024 Q4	$90.2K	Hold	38,200	–	–	﹤0.01%	3135
2024 Q3	$1.12M	Hold	38,200	–	–	﹤0.01%	2260
2024 Q2	$472K	Hold	38,200	–	–	﹤0.01%	2702
2024 Q1	$775K	Hold	38,200	–	–	﹤0.01%	2394
2023 Q4	$860K	Hold	38,200	–	–	﹤0.01%	2348
2023 Q3	$636K	Hold	38,200	–	–	﹤0.01%	2453
2023 Q2	$937K	Hold	38,200	–	–	﹤0.01%	2317
2023 Q1	$921K	Hold	38,200	–	–	﹤0.01%	2270
2022 Q4	$1.13M	Hold	38,200	–	–	﹤0.01%	2212
2022 Q3	$1.6M	Hold	38,200	–	–	﹤0.01%	2030
2022 Q2	$1.07M	Buy	38,200 +800	+2%	+$20.2K	﹤0.01%	2305
2022 Q1	$1.39M	Buy	37,400 +100	+0.3%	+$4.24K	﹤0.01%	2296
2021 Q4	$1.63M	Sell	37,300 -400	-1%	-$21K	﹤0.01%	2253
2021 Q3	$2.34M	Sell	37,700 -7,500	-17%	-$626K	﹤0.01%	2076
2021 Q2	$3.86M	Buy	45,200 +8,300	+22%	+$445K	﹤0.01%	1774
2021 Q1	$1.66M	Sell	36,900 -50,600	-58%	-$1.99M	﹤0.01%	2198
2020 Q4	$597K	Sell	87,500 -37,900	-30%	-$338K	﹤0.01%	2510
2020 Q3	$1.44M	Hold	125,400	–	–	﹤0.01%	2019
2020 Q2	$386K	Buy	+125,400	New	+$569K	﹤0.01%	2765
2015 Q2	–	Sell	-286	Closed	-$4K	–	3224
2015 Q1	$4K	Hold	286	–	–	﹤0.01%	3440
2014 Q4	$4K	Hold	286	–	–	﹤0.01%	3387
2014 Q3	$8K	Sell	286 -343	-55%	-$10.4K	﹤0.01%	3313
2014 Q2	$25K	Buy	629 +547	+667%	+$20.2K	﹤0.01%	3203
2014 Q1	$3K	Hold	82	–	–	﹤0.01%	3381
2013 Q4	$3K	Hold	82	–	–	﹤0.01%	3191
2013 Q3	$2K	Sell	82 -2,403	-97%	-$42K	﹤0.01%	3261
2013 Q2	$38K	Buy	+2,485	New	+$52.5K	﹤0.01%	3013

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

AllianceBernstein's FLNA Position: Q2 2025 in Review

AllianceBernstein sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 37,000 shares — an estimated $55.5K sold.

AllianceBernstein first reported a position in FLNA in Q2 2013 and held it in 28 quarters. The position peaked at $3.86M in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

AllianceBernstein reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 37,000 Filana Therapeutics shares in Q2 2025, an estimated $55.5K.
AllianceBernstein first reported a position in Filana Therapeutics in Q2 2013 and held it in 28 quarters.
AllianceBernstein's Filana Therapeutics position peaked at $3.86M in Q2 2021.
97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.